HEADER TRANSFERASE 27-MAR-07 2PAA TITLE CRYSTAL STRUCTURE OF PHOSPHOGLYCERATE KINASE-2 BOUND TO ATP AND 3PG COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHOGLYCERATE KINASE, TESTIS SPECIFIC; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.7.2.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 STRAIN: C3H/HE; SOURCE 6 GENE: PGK2, PGK-2; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGK-2-PGEX4T3 KEYWDS TRANSFERASE, PHOSPHOGLYCERATE KINASE, ENZYME-LIGAND COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.M.SAWYER,A.F.MONZINGO,E.C.POTEET,J.D.ROBERTUS REVDAT 5 30-AUG-23 2PAA 1 REMARK REVDAT 4 18-OCT-17 2PAA 1 REMARK REVDAT 3 24-FEB-09 2PAA 1 VERSN REVDAT 2 22-APR-08 2PAA 1 JRNL REVDAT 1 27-NOV-07 2PAA 0 JRNL AUTH G.M.SAWYER,A.F.MONZINGO,E.C.POTEET,D.A.O'BRIEN,J.D.ROBERTUS JRNL TITL X-RAY ANALYSIS OF PHOSPHOGLYCERATE KINASE 2, A JRNL TITL 2 SPERM-SPECIFIC ISOFORM FROM MUS MUSCULUS. JRNL REF PROTEINS V. 71 1134 2007 JRNL REFN ISSN 0887-3585 JRNL PMID 18004764 JRNL DOI 10.1002/PROT.21801 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.1 REMARK 3 NUMBER OF REFLECTIONS : 18535 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.271 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 947 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 18 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.75 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 538 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE : 0.3690 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 24 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6055 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 28 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.53300 REMARK 3 B22 (A**2) : 2.37800 REMARK 3 B33 (A**2) : 3.15400 REMARK 3 B12 (A**2) : -2.56800 REMARK 3 B13 (A**2) : 4.71200 REMARK 3 B23 (A**2) : 1.55100 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.248 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.117 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.776 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.719 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 10.00 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : ATP-3PG.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : ATP-3PG.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2PAA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1000042163. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH3R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : BLUE MAX-FLUX CONFOCAL REMARK 200 OPTICS : BLUE MAX-FLUX CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19197 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.12500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1VJD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG6000, 0.1 M BICINE, 10 MM 3-D REMARK 280 -PHOSPHOGLYCERATE, 5 MM ATP, PH 9.0, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 LEU A 2 REMARK 465 SER A 3 REMARK 465 ALA B 1 REMARK 465 LEU B 2 REMARK 465 SER B 3 REMARK 465 GLY B 372 REMARK 465 GLY B 373 REMARK 465 ASP B 374 REMARK 465 THR B 375 REMARK 465 ALA B 376 REMARK 465 THR B 377 REMARK 465 CYS B 378 REMARK 465 CYS B 379 REMARK 465 ALA B 380 REMARK 465 LYS B 381 REMARK 465 TRP B 382 REMARK 465 GLY B 383 REMARK 465 THR B 384 REMARK 465 GLU B 385 REMARK 465 ASP B 386 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 14 CG CD CE NZ REMARK 470 LYS A 29 CG CD CE NZ REMARK 470 LYS A 47 CG CD CE NZ REMARK 470 LYS A 198 CG CD CE NZ REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 LYS B 14 CG CD CE NZ REMARK 470 LYS B 29 CG CD CE NZ REMARK 470 GLN B 37 CG CD OE1 NE2 REMARK 470 ARG B 65 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 190 CG CD CE NZ REMARK 470 LYS B 198 CG CD CE NZ REMARK 470 GLU B 260 CG CD OE1 OE2 REMARK 470 LYS B 274 CG CD CE NZ REMARK 470 LYS B 278 CG CD CE NZ REMARK 470 LYS B 296 CG CD CE NZ REMARK 470 GLN B 299 CG CD OE1 NE2 REMARK 470 GLU B 303 CG CD OE1 OE2 REMARK 470 GLU B 318 CG CD OE1 OE2 REMARK 470 LYS B 331 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 33 100.85 72.75 REMARK 500 ASN A 35 100.22 -174.77 REMARK 500 SER A 61 -167.53 -165.66 REMARK 500 LYS A 74 -13.40 -141.43 REMARK 500 LEU A 156 -6.34 -57.48 REMARK 500 LEU A 200 -45.31 -132.66 REMARK 500 ASN A 249 42.56 36.50 REMARK 500 LYS A 290 149.35 -178.80 REMARK 500 ASN A 294 48.12 -109.89 REMARK 500 ASN A 415 -132.28 -106.99 REMARK 500 ASP B 9 -1.84 -58.33 REMARK 500 ASN B 30 75.04 58.55 REMARK 500 ASN B 31 39.04 34.88 REMARK 500 ASN B 35 113.06 -166.46 REMARK 500 ASP B 67 71.37 55.46 REMARK 500 MET B 71 55.73 -146.51 REMARK 500 LYS B 74 -25.88 -157.49 REMARK 500 ASN B 109 76.89 -156.62 REMARK 500 VAL B 178 92.69 -68.22 REMARK 500 GLU B 201 -48.47 -134.27 REMARK 500 LEU B 227 -8.27 -54.37 REMARK 500 LEU B 247 -88.59 -57.84 REMARK 500 LYS B 248 4.47 -60.48 REMARK 500 LYS B 290 142.26 -170.62 REMARK 500 ASN B 294 58.72 -90.94 REMARK 500 ALA B 300 160.99 178.22 REMARK 500 ASN B 364 36.31 -91.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3PG B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2P9Q RELATED DB: PDB REMARK 900 APO PHOSPHOGLYCERATE KINASE-2 REMARK 900 RELATED ID: 2P9T RELATED DB: PDB REMARK 900 PHOSPHOGLYCERATE KINASE-2 BOUND TO 3PG REMARK 999 REMARK 999 SEQUENCE REMARK 999 THERE IS A GLN -> ARG SEQUENCE CONFLICT AT RESIDUE 151 IN REMARK 999 THE UNIPROT DATABASE. AUTHORS STATE THAT PROTEIN SEQUENCE REMARK 999 USED IN THIS PDB ENTRY IS FROM C3H/HE STRAIN WHICH HAS REMARK 999 ARG AT RESIDUE 150, WHEREAS UNIPROT SEQUENCE IS FROM REMARK 999 BALB/C STRAIN THAT HAS GLN AT RESIDUE 151. DBREF 2PAA A 1 416 UNP P09041 PGK2_MOUSE 2 417 DBREF 2PAA B 1 416 UNP P09041 PGK2_MOUSE 2 417 SEQADV 2PAA ARG A 150 UNP P09041 GLN 151 SEE REMARK 999 SEQADV 2PAA ARG B 150 UNP P09041 GLN 151 SEE REMARK 999 SEQRES 1 A 416 ALA LEU SER ALA LYS LEU THR LEU ASP LYS VAL ASP LEU SEQRES 2 A 416 LYS GLY LYS ARG VAL ILE MET ARG VAL ASP PHE ASN VAL SEQRES 3 A 416 PRO MET LYS ASN ASN GLN ILE THR ASN ASN GLN ARG ILE SEQRES 4 A 416 LYS ALA ALA ILE PRO SER ILE LYS HIS CYS LEU ASP ASN SEQRES 5 A 416 GLY ALA LYS SER VAL VAL LEU MET SER HIS LEU GLY ARG SEQRES 6 A 416 PRO ASP GLY ILE PRO MET PRO ASP LYS TYR SER LEU GLU SEQRES 7 A 416 PRO VAL ALA ASP GLU LEU LYS SER LEU LEU ASN LYS ASP SEQRES 8 A 416 VAL ILE PHE LEU LYS ASP CYS VAL GLY PRO GLU VAL GLU SEQRES 9 A 416 GLN ALA CYS ALA ASN PRO ASP ASN GLY SER ILE ILE LEU SEQRES 10 A 416 LEU GLU ASN LEU ARG PHE HIS VAL GLU GLU GLU GLY LYS SEQRES 11 A 416 GLY LYS ASP SER SER GLY LYS LYS ILE SER ALA ASP PRO SEQRES 12 A 416 ALA LYS VAL GLU ALA PHE ARG ALA SER LEU SER LYS LEU SEQRES 13 A 416 GLY ASP VAL TYR VAL ASN ASP ALA PHE GLY THR ALA HIS SEQRES 14 A 416 ARG ALA HIS SER SER MET VAL GLY VAL ASN LEU PRO GLN SEQRES 15 A 416 LYS ALA SER GLY PHE LEU MET LYS LYS GLU LEU ASP TYR SEQRES 16 A 416 PHE SER LYS ALA LEU GLU LYS PRO GLU ARG PRO PHE LEU SEQRES 17 A 416 ALA ILE LEU GLY GLY ALA LYS VAL LYS ASP LYS ILE GLN SEQRES 18 A 416 LEU ILE LYS ASN MET LEU ASP LYS VAL ASN PHE MET ILE SEQRES 19 A 416 ILE GLY GLY GLY MET ALA TYR THR PHE LEU LYS GLU LEU SEQRES 20 A 416 LYS ASN MET GLN ILE GLY ALA SER LEU PHE ASP GLU GLU SEQRES 21 A 416 GLY ALA THR ILE VAL LYS GLU ILE MET GLU LYS ALA GLU SEQRES 22 A 416 LYS ASN GLY VAL LYS ILE VAL PHE PRO VAL ASP PHE VAL SEQRES 23 A 416 THR GLY ASP LYS PHE ASP GLU ASN ALA LYS VAL GLY GLN SEQRES 24 A 416 ALA THR ILE GLU SER GLY ILE PRO SER GLY TRP MET GLY SEQRES 25 A 416 LEU ASP CYS GLY PRO GLU SER ILE LYS ILE ASN ALA GLN SEQRES 26 A 416 ILE VAL ALA GLN ALA LYS LEU ILE VAL TRP ASN GLY PRO SEQRES 27 A 416 ILE GLY VAL PHE GLU TRP ASP ALA PHE ALA LYS GLY THR SEQRES 28 A 416 LYS ALA LEU MET ASP GLU VAL VAL LYS ALA THR SER ASN SEQRES 29 A 416 GLY CYS VAL THR ILE ILE GLY GLY GLY ASP THR ALA THR SEQRES 30 A 416 CYS CYS ALA LYS TRP GLY THR GLU ASP LYS VAL SER HIS SEQRES 31 A 416 VAL SER THR GLY GLY GLY ALA SER LEU GLU LEU LEU GLU SEQRES 32 A 416 GLY LYS ILE LEU PRO GLY VAL GLU ALA LEU SER ASN MET SEQRES 1 B 416 ALA LEU SER ALA LYS LEU THR LEU ASP LYS VAL ASP LEU SEQRES 2 B 416 LYS GLY LYS ARG VAL ILE MET ARG VAL ASP PHE ASN VAL SEQRES 3 B 416 PRO MET LYS ASN ASN GLN ILE THR ASN ASN GLN ARG ILE SEQRES 4 B 416 LYS ALA ALA ILE PRO SER ILE LYS HIS CYS LEU ASP ASN SEQRES 5 B 416 GLY ALA LYS SER VAL VAL LEU MET SER HIS LEU GLY ARG SEQRES 6 B 416 PRO ASP GLY ILE PRO MET PRO ASP LYS TYR SER LEU GLU SEQRES 7 B 416 PRO VAL ALA ASP GLU LEU LYS SER LEU LEU ASN LYS ASP SEQRES 8 B 416 VAL ILE PHE LEU LYS ASP CYS VAL GLY PRO GLU VAL GLU SEQRES 9 B 416 GLN ALA CYS ALA ASN PRO ASP ASN GLY SER ILE ILE LEU SEQRES 10 B 416 LEU GLU ASN LEU ARG PHE HIS VAL GLU GLU GLU GLY LYS SEQRES 11 B 416 GLY LYS ASP SER SER GLY LYS LYS ILE SER ALA ASP PRO SEQRES 12 B 416 ALA LYS VAL GLU ALA PHE ARG ALA SER LEU SER LYS LEU SEQRES 13 B 416 GLY ASP VAL TYR VAL ASN ASP ALA PHE GLY THR ALA HIS SEQRES 14 B 416 ARG ALA HIS SER SER MET VAL GLY VAL ASN LEU PRO GLN SEQRES 15 B 416 LYS ALA SER GLY PHE LEU MET LYS LYS GLU LEU ASP TYR SEQRES 16 B 416 PHE SER LYS ALA LEU GLU LYS PRO GLU ARG PRO PHE LEU SEQRES 17 B 416 ALA ILE LEU GLY GLY ALA LYS VAL LYS ASP LYS ILE GLN SEQRES 18 B 416 LEU ILE LYS ASN MET LEU ASP LYS VAL ASN PHE MET ILE SEQRES 19 B 416 ILE GLY GLY GLY MET ALA TYR THR PHE LEU LYS GLU LEU SEQRES 20 B 416 LYS ASN MET GLN ILE GLY ALA SER LEU PHE ASP GLU GLU SEQRES 21 B 416 GLY ALA THR ILE VAL LYS GLU ILE MET GLU LYS ALA GLU SEQRES 22 B 416 LYS ASN GLY VAL LYS ILE VAL PHE PRO VAL ASP PHE VAL SEQRES 23 B 416 THR GLY ASP LYS PHE ASP GLU ASN ALA LYS VAL GLY GLN SEQRES 24 B 416 ALA THR ILE GLU SER GLY ILE PRO SER GLY TRP MET GLY SEQRES 25 B 416 LEU ASP CYS GLY PRO GLU SER ILE LYS ILE ASN ALA GLN SEQRES 26 B 416 ILE VAL ALA GLN ALA LYS LEU ILE VAL TRP ASN GLY PRO SEQRES 27 B 416 ILE GLY VAL PHE GLU TRP ASP ALA PHE ALA LYS GLY THR SEQRES 28 B 416 LYS ALA LEU MET ASP GLU VAL VAL LYS ALA THR SER ASN SEQRES 29 B 416 GLY CYS VAL THR ILE ILE GLY GLY GLY ASP THR ALA THR SEQRES 30 B 416 CYS CYS ALA LYS TRP GLY THR GLU ASP LYS VAL SER HIS SEQRES 31 B 416 VAL SER THR GLY GLY GLY ALA SER LEU GLU LEU LEU GLU SEQRES 32 B 416 GLY LYS ILE LEU PRO GLY VAL GLU ALA LEU SER ASN MET HET ATP A 500 31 HET 3PG B 501 11 HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM 3PG 3-PHOSPHOGLYCERIC ACID FORMUL 3 ATP C10 H16 N5 O13 P3 FORMUL 4 3PG C3 H7 O7 P FORMUL 5 HOH *28(H2 O) HELIX 1 1 THR A 7 VAL A 11 5 5 HELIX 2 2 ASN A 36 ASN A 52 1 17 HELIX 3 3 MET A 71 SER A 76 1 6 HELIX 4 4 LEU A 77 ASN A 89 1 13 HELIX 5 5 GLY A 100 CYS A 107 1 8 HELIX 6 6 ASN A 120 PHE A 123 5 4 HELIX 7 7 HIS A 124 GLY A 129 1 6 HELIX 8 8 ASP A 142 LEU A 156 1 15 HELIX 9 9 ALA A 164 ALA A 168 5 5 HELIX 10 10 HIS A 172 GLY A 177 1 6 HELIX 11 11 GLY A 186 ALA A 199 1 14 HELIX 12 12 LYS A 219 ASP A 228 1 10 HELIX 13 13 GLY A 238 LYS A 248 1 11 HELIX 14 14 GLU A 260 THR A 263 5 4 HELIX 15 15 ILE A 264 ASN A 275 1 12 HELIX 16 16 GLY A 316 ALA A 328 1 13 HELIX 17 17 TRP A 344 PHE A 347 5 4 HELIX 18 18 ALA A 348 ASN A 364 1 17 HELIX 19 19 GLY A 373 TRP A 382 1 10 HELIX 20 20 GLY A 394 GLY A 404 1 11 HELIX 21 21 LEU A 407 ALA A 412 1 6 HELIX 22 22 THR B 7 VAL B 11 5 5 HELIX 23 23 ASN B 36 ALA B 41 1 6 HELIX 24 24 ALA B 42 ASN B 52 1 11 HELIX 25 25 LEU B 77 ASN B 89 1 13 HELIX 26 26 GLY B 100 ASN B 109 1 10 HELIX 27 27 ASN B 120 HIS B 124 5 5 HELIX 28 28 ASP B 142 LYS B 155 1 14 HELIX 29 29 ALA B 164 ALA B 168 5 5 HELIX 30 30 HIS B 172 GLY B 177 1 6 HELIX 31 31 GLY B 186 LYS B 202 1 17 HELIX 32 32 VAL B 216 ASP B 218 5 3 HELIX 33 33 LYS B 219 VAL B 230 1 12 HELIX 34 34 MET B 239 LEU B 247 1 9 HELIX 35 35 GLU B 260 ASN B 275 1 16 HELIX 36 36 GLY B 316 ALA B 328 1 13 HELIX 37 37 TRP B 344 PHE B 347 5 4 HELIX 38 38 ALA B 348 ASN B 364 1 17 HELIX 39 39 GLY B 394 GLY B 404 1 11 HELIX 40 40 LEU B 407 ALA B 412 1 6 SHEET 1 A 6 ILE A 93 PHE A 94 0 SHEET 2 A 6 SER A 114 LEU A 117 1 O ILE A 115 N ILE A 93 SHEET 3 A 6 SER A 56 MET A 60 1 N LEU A 59 O ILE A 116 SHEET 4 A 6 ARG A 17 VAL A 22 1 N VAL A 18 O VAL A 58 SHEET 5 A 6 VAL A 159 ASP A 163 1 O ASP A 163 N ARG A 21 SHEET 6 A 6 LYS A 183 SER A 185 1 O ALA A 184 N ASN A 162 SHEET 1 B 2 LYS A 130 LYS A 132 0 SHEET 2 B 2 LYS A 138 SER A 140 -1 O ILE A 139 N GLY A 131 SHEET 1 C 6 LYS A 278 VAL A 280 0 SHEET 2 C 6 PHE A 232 ILE A 235 1 N MET A 233 O VAL A 280 SHEET 3 C 6 PHE A 207 LEU A 211 1 N LEU A 211 O ILE A 234 SHEET 4 C 6 LEU A 332 ASN A 336 1 O VAL A 334 N ILE A 210 SHEET 5 C 6 VAL A 367 ILE A 370 1 O ILE A 369 N ILE A 333 SHEET 6 C 6 HIS A 390 VAL A 391 1 O HIS A 390 N ILE A 370 SHEET 1 D 3 VAL A 297 THR A 301 0 SHEET 2 D 3 ASP A 284 GLY A 288 -1 N PHE A 285 O ALA A 300 SHEET 3 D 3 MET A 311 CYS A 315 -1 O ASP A 314 N VAL A 286 SHEET 1 E 6 ILE B 93 PHE B 94 0 SHEET 2 E 6 SER B 114 LEU B 117 1 O LEU B 117 N ILE B 93 SHEET 3 E 6 SER B 56 MET B 60 1 N LEU B 59 O ILE B 116 SHEET 4 E 6 ARG B 17 ARG B 21 1 N MET B 20 O VAL B 58 SHEET 5 E 6 VAL B 159 ASN B 162 1 O VAL B 161 N ILE B 19 SHEET 6 E 6 LYS B 183 SER B 185 1 O ALA B 184 N TYR B 160 SHEET 1 F 2 LYS B 130 LYS B 132 0 SHEET 2 F 2 LYS B 138 SER B 140 -1 O ILE B 139 N GLY B 131 SHEET 1 G 5 PHE B 232 ILE B 235 0 SHEET 2 G 5 PHE B 207 LEU B 211 1 N ALA B 209 O ILE B 234 SHEET 3 G 5 LEU B 332 ASN B 336 1 O VAL B 334 N ILE B 210 SHEET 4 G 5 VAL B 367 ILE B 370 1 O ILE B 369 N ILE B 333 SHEET 5 G 5 HIS B 390 VAL B 391 1 O HIS B 390 N ILE B 370 SHEET 1 H 3 VAL B 297 THR B 301 0 SHEET 2 H 3 ASP B 284 GLY B 288 -1 N PHE B 285 O ALA B 300 SHEET 3 H 3 MET B 311 CYS B 315 -1 O MET B 311 N GLY B 288 CISPEP 1 ARG A 205 PRO A 206 0 -0.19 CISPEP 2 ARG B 205 PRO B 206 0 0.14 SITE 1 AC1 18 GLY A 212 GLY A 213 ALA A 214 LYS A 219 SITE 2 AC1 18 GLY A 237 GLY A 238 LEU A 256 GLY A 312 SITE 3 AC1 18 LEU A 313 ASN A 336 GLY A 337 PRO A 338 SITE 4 AC1 18 GLY A 340 VAL A 341 GLU A 343 GLY A 373 SITE 5 AC1 18 ASP A 374 THR A 375 SITE 1 AC2 4 HIS B 62 ARG B 122 GLY B 166 ARG B 170 CRYST1 39.854 64.541 75.936 90.34 77.20 85.03 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025092 -0.002182 -0.005759 0.00000 SCALE2 0.000000 0.015553 0.000402 0.00000 SCALE3 0.000000 0.000000 0.013509 0.00000